TR201721700A2 - Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari - Google Patents

Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari Download PDF

Info

Publication number
TR201721700A2
TR201721700A2 TR2017/21700A TR201721700A TR201721700A2 TR 201721700 A2 TR201721700 A2 TR 201721700A2 TR 2017/21700 A TR2017/21700 A TR 2017/21700A TR 201721700 A TR201721700 A TR 201721700A TR 201721700 A2 TR201721700 A2 TR 201721700A2
Authority
TR
Turkey
Prior art keywords
saxaglipt
formulations
mouth
distributed
pharmaceutically acceptable
Prior art date
Application number
TR2017/21700A
Other languages
English (en)
Inventor
Kaplan Gülcan
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/21700A priority Critical patent/TR201721700A2/tr
Priority to PCT/TR2018/050869 priority patent/WO2019151964A2/en
Publication of TR201721700A2 publication Critical patent/TR201721700A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, saksagliptin veya farmasötik olarak kabul edilebilir bir tuzunu ve bir veya daha fazla farmasötik olarak kabul edilebilir eksipiyan içeren ağızda dağılan bir farmasötik formülasyon ile ilgilidir.
TR2017/21700A 2017-12-26 2017-12-26 Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari TR201721700A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/21700A TR201721700A2 (tr) 2017-12-26 2017-12-26 Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
PCT/TR2018/050869 WO2019151964A2 (en) 2017-12-26 2018-12-24 Orally disintegrating formulations of saxagliptin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/21700A TR201721700A2 (tr) 2017-12-26 2017-12-26 Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari

Publications (1)

Publication Number Publication Date
TR201721700A2 true TR201721700A2 (tr) 2019-07-22

Family

ID=67479379

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/21700A TR201721700A2 (tr) 2017-12-26 2017-12-26 Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari

Country Status (2)

Country Link
TR (1) TR201721700A2 (tr)
WO (1) WO2019151964A2 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114869904A (zh) * 2022-05-09 2022-08-09 广州汉光药业股份有限公司 复方维生素自乳化给药系统及其制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR202009724A2 (tr) * 2020-06-23 2022-01-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Si̇tagli̇pti̇ni̇n ağizda dağilan tablet formülasyonu

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114869904A (zh) * 2022-05-09 2022-08-09 广州汉光药业股份有限公司 复方维生素自乳化给药系统及其制备方法
CN114869904B (zh) * 2022-05-09 2023-10-20 广州汉光药业股份有限公司 复方维生素自乳化给药系统及其制备方法

Also Published As

Publication number Publication date
WO2019151964A3 (en) 2019-10-31
WO2019151964A2 (en) 2019-08-08

Similar Documents

Publication Publication Date Title
CY1124007T1 (el) Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης
ECSP17084331A (es) Formulaciones farmacéuticas
EA201792591A1 (ru) Фармацевтические препараты
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
WO2019016673A3 (en) STABLE PHARMACEUTICAL COMPOSITION OF ORAL ADMINISTRATION OF IMATINIB
TR201713954A2 (tr) Tenofovir, emtrisitabin ve efavirenzin farmasötik kombinasyonlari
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
TR201721036A2 (tr) Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
TR201914416A1 (tr) Sapropteri̇n di̇hi̇droklorürün efervesan formülasyonlari
TR201821106A2 (tr) Meti̇l paraben ve propi̇l parabensi̇z aseti̇lsi̇stei̇n i̇çeren farmasöti̇k bi̇leşi̇m
TN2016000561A1 (en) Stabilized desmopressin
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
TR201720510A2 (tr) Orally disintegrating tablet formulations of ivabradine
JOP20170198A1 (ar) صيغ صيدلية تشتمل على تينوفوفير و إيمترايسيتابين
CY1119636T1 (el) Φαρμακευτικο παρασκευασμα με βαση διοσμεκτιτη
CY1123966T1 (el) Διαδικασια για την παρασκευη νατριουχου εποπροστενολης ενισχυμενης σταθεροτητας
TR201721065A2 (tr) Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar